Expertise in
8
conditions

Xudong -. Yao

No. 301, Yanchang Road, 
Jing'an, CN 
Expertise in
8
conditions
No. 301, Yanchang Road, 
Jing'an, CN 
OverviewLocationsClinical Research

Overview

Xudong Yao practices in Jing'an, China. Yao is highly rated in 8 conditions, according to our data. Their top areas of expertise are Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Lithotripsy.

Their clinical research consists of co-authoring 224 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

No. 301, Yanchang Road, Jing'an, 200072, China
Other Locations
301 Middle Yan Chang Road, Shanghai, 200072, China
81 Meishan Road, Hefei, 230032, China
No. N1, Shangcheng Avenue, Yiwu, 322000, China
Yan Chang Zhong Road 301, Shanghai, 200072, China
No. 301, Middle Yan Chang Rd, Jing'an, 200072, China
Chongming Branch, Shanghai, China
Chongming Branch, No.66 Xiangyang Road, Chengqiao, 202157, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
A Randomized, Positive Parallel Controlled, Multicenter Phase III Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
A Randomized, Positive Parallel Controlled, Multicenter Phase III Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: TQB2450, Anlotinib, Sunitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

224 Total Publications

Advanced 3D Bioprinting Technology for Cartilage Engineering and Regeneration.
Advanced 3D Bioprinting Technology for Cartilage Engineering and Regeneration.
Journal: ACS biomaterials science & engineering
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yao's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile